Found: 9
Select item for more details and to access through your institution.
Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02293-9
- By:
- Publication type:
- Article
Straightforward Synthesis of Pentagon‐Embedded Expanded [11]Helicenes for Radiative Cooling Property.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 3, p. 1, doi. 10.1002/chem.202302893
- By:
- Publication type:
- Article
Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.944886
- By:
- Publication type:
- Article
Understanding the shift to compulsion in addiction: insights from personality traits, social factors, and neurobiology.
- Published in:
- Frontiers in Psychology, 2024, p. 1, doi. 10.3389/fpsyg.2024.1416222
- By:
- Publication type:
- Article
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.708494
- By:
- Publication type:
- Article
Relationships Between Perivascular Adipose Tissue and Abdominal Aortic Aneurysms.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.704845
- By:
- Publication type:
- Article
Brusatol's anticancer activity and its molecular mechanism: a research update.
- Published in:
- Journal of Pharmacy & Pharmacology, 2024, v. 76, n. 7, p. 753, doi. 10.1093/jpp/rgae017
- By:
- Publication type:
- Article
Preparation of Natural Composite Microcapsules Containing Orchid Black Currant Fragrance and its Sustained-Release Properties on Hair Bundle.
- Published in:
- Journal of Polymers & the Environment, 2022, v. 30, n. 1, p. 136, doi. 10.1007/s10924-021-02173-8
- By:
- Publication type:
- Article
Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.907984
- By:
- Publication type:
- Article